Alliance Pharma PLC has received a notification of major holdings from Rathbones Investment Management Ltd. The increase in shareholding is a result of the all-share combination of Rathbones Group Plc with Investec Wealth & Investment Limited, which was completed on September 21, 2023. The notification states that Rathbones Investment Management Ltd now holds 5.411400% of the voting rights in Alliance Pharma, with a total of 29,229,942 voting rights.

The notification also provides details of the shareholder, which includes Hero Nominees Limited, Ferlim Nominees Limited, and Rathbone Nominees Limited. The date on which the threshold was crossed or reached is September 21, 2023, and the issuer was notified on September 25, 2023.

The notification further breaks down the voting rights attached to shares, stating that Rathbones Investment Management Ltd holds 29,229,942 direct voting rights, representing 5.411400% of the total voting rights. No information is provided regarding financial instruments or proxy voting.

Overall, the notification highlights the increase in shareholding by Rathbones Investment Management Ltd in Alliance Pharma PLC as a result of the all-share combination with Investec Wealth & Investment Limited.